The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
- 5 July 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (30), 4680-4690
- https://doi.org/10.1038/sj.onc.1205578
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 42 references indexed in Scilit:
- Rescue of Cyclin D1 Deficiency by Knockin Cyclin ECell, 1999
- The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblastsThe EMBO Journal, 1999
- Cyclin D1 in Breast CancerBreast Cancer Research and Treatment, 1998
- Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteinsThe EMBO Journal, 1997
- Cyclin D1 and prognosis in human breast cancerInternational Journal of Cancer, 1996
- Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.Proceedings of the National Academy of Sciences, 1995
- Mammalian G1 cyclinsCurrent Opinion in Cell Biology, 1994
- Cyclin D1 protein expression and function in human breast cancerInternational Journal of Cancer, 1994
- Diversity of human p53 mutants revealed by complex formation to SV40 T antigenEuropean Journal Of Cancer, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991